The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy

BACKGROUND: To observe the effect of alogliptin combined with metformin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy (500 mg, bid po, for at least 3 months), and evaluate its efficacy and safety. METHODS: After a 2-week screening perio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, He, Wang, Ming-Yue, Zhao, Yue-Ping, Li, Ling-Bing, Dong, Qian-Yan, Liu, Xin-Guang, Kuang, Jin-Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370803/
https://www.ncbi.nlm.nih.gov/pubmed/27537577
http://dx.doi.org/10.1097/MD.0000000000004541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370803/
https://www.ncbi.nlm.nih.gov/pubmed/27537577
http://dx.doi.org/10.1097/MD.0000000000004541

Ejemplares similares